Explore
Validate
LearnAP21692SU-S
antibody from Acris Antibodies GmbH
Targeting: BIRC2
API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48
Western blot
ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AP21692SU-S - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#AP21692SU-S, RRID:AB_10756327
- Product name
- anti IAP2 / BIRC2
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to amino acids 158-175 (PNPLNSRAVEDISSSRTN) of human cIAP1
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 50 µl
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western blot analysis of cIAP1 in various cancer cell lines using AP21692SU-S at 1/2000.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Immunhistochemical analysis of cIAP1 expression in formalin-fixed, paraffin-embedded human gliomas from a brain tissue microarray using AP21692SU-S at 1/2000. A. Two tissue cores showing a gemistocytoma, grade II tumor (left) and an anaplastic glioma-glioblastoma, grade IV tumor (right). A1 and A2, higher magnifications of the gemistocytoma. A3, higher magnification of the anaplastic glioma-glioblastoma. Hematoxylin-eosin counterstain. Higher cIAP1 expression is seen in the less malignant tumor (gemistocytoma) than the more malignant anaplastic (glioma-glioblastoma) tumor.
